Different Doses of Naronapride vs. Placebo in Gastroparesis

NCT05621811 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroparesis

Interventions

DRUG: Naronapride
DRUG: Placebo

Sponsor

Dr. Falk Pharma GmbH